| 肾癌的药物治疗 |
| |
| 引用本文： | 康马飞.肾癌的药物治疗[J].国际肿瘤学杂志,2008,35(6). |
| |
| 作者姓名： | 康马飞 |
| |
| 作者单位： | 桂林医学院附属医院肿瘤科,541001 |
| |
| 摘 要： | 肾癌的药物治疗目前仍以免疫化学治疗为主,单纯化疗也有效,吉西他滨联合顺铂是目前的标准化疗方案.靶向治疗药物的出现使肾癌的治疗发生了改变,多靶点受体酪氨酸激酶抑制剂(如舒尼替尼和索拉非尼)、哺乳动物雷帕霉素靶蛋白抑制剂(temsirolimus)和抗肿瘤单克隆抗体(如贝伐单抗)等已成为肾癌的一线治疗选择.
|
| 关 键 词： | 肾肿瘤 药物疗法 化学疗法 免疫疗法 |
Drug therapy of renal cell carcinoma |
| |
| KANG Ma-fei.Drug therapy of renal cell carcinoma[J].Journal of International Oncology,2008,35(6). |
| |
| Authors: | KANG Ma-fei |
| |
| Abstract: | Immunochemotherapy is still the primary drug therapy of renal cell carcinoma(RCC), and chemotherapy is effective too. The combination of gemcitabine and cisplatin is the standard regimen now. How-ever, emerge of targeted therapeutic agents has altered the treatment of RCC. Multitargeted tyrosine kinase in-hibitor, such as sunitinib and sorafenib, and mammalian target of rapamycin (roTOR) inhibitors( temsiroll-mus), and anti-tumor monoclonal antibody, such as bevacizumab, have already become the first line election. |
| |
| Keywords: | Kidney neoplasms Drug therapy Chemotherapy Immunotherapy |
| 本文献已被 万方数据 等数据库收录！ |
|
